Skip to main content
. 2015 May 28;12(3):3381–3385. doi: 10.3892/mmr.2015.3869

Figure 1.

Figure 1

GSK1904529A suppresses glioma cell viability. (A) U87MG cells were treated with GSK1904529A (6.25–400 nM) for 72 h, followed by measurement of cell viability using a viability assay. (B) U87MG cells were treated with GSK1904529A (100 nM) for 24, 48 or 72 h, followed by measurement of the effects on the inhibition of viability. Data are expressed as the mean ± standard deviation.